| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | lysine | 0.3451 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.4447 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.4467 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.4487 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.4496 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.4668 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.4761 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.4792 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.4935 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5199 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5548 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5558 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5574 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5674 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5690 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5696 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5880 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5899 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5923 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5958 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.5976 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6065 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6210 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6302 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6337 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6351 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6509 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6600 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6614 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6680 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6704 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6729 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6820 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6872 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6933 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6949 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.6981 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7053 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7059 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7061 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7084 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 0.7096 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7120 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 0.7129 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7207 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7217 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7227 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7327 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7447 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7494 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7623 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7639 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7715 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7729 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7754 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7789 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7792 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7910 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7958 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7958 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.7974 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8113 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8128 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8195 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8202 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8285 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8360 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8372 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8490 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8500 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8566 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8572 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8649 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8714 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8814 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8848 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8956 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8970 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.8987 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.9044 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 0.9199 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.9237 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.9429 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.9458 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.9512 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 0.9609 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.9666 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.9736 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 0.9812 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 0.9861 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 0.9899 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 0.9948 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.0000 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.0052 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.0110 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.0284 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.0313 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.0458 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.0495 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.0505 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.0602 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.0629 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.0632 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.0709 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.0785 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.0808 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.0874 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.0912 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.0944 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1015 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1017 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.1106 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1366 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1368 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1372 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.1381 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.1486 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1510 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1524 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1537 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1584 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.1707 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1711 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1757 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.1758 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.1806 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.1821 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.1889 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.1893 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.1908 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.1911 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.1957 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.2049 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.2170 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.2239 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.2354 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.2439 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.2442 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.2461 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.2542 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.2566 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.2566 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.2583 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.2594 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.2651 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.2656 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.2723 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.2736 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.2811 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.2858 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.2862 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.2895 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.2919 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.2948 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.3145 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.3155 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.3192 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.3201 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.3310 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.3311 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.3347 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.3371 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.3382 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.3395 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.3445 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.3508 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.3577 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.3716 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.3737 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.3770 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.3854 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.3919 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.3935 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.3961 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.4005 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.4041 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.4357 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.4409 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.4424 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.4720 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.4773 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.5617 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | lysine | 1.5699 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.5751 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | lysine | 1.6916 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | lysine | 1.7244 | scaled units | Placebo | BASELINE |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|